ADJUVANT CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED BLADDER CANCER: A STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP — Aristotle Bamias (2004) | RDL Network
ADJUVANT CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED BLADDER CANCER: A STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Article 2004 en
Authors
AB
Aristotle Bamias
CD
Ch. Deliveliotis
GA
Gerasimos Aravantinos
Abstract
1 min read
Adjuvant chemotherapy with paclitaxel and carboplatin is feasible and could be used as adjuvant treatment for high risk bladder carcinoma. Its true value should be assessed in prospective, randomized trials.
Gerasimos Aravantinos, George Fountzilas, Haralabos P. Kalofonos, D. Skarlos, P. Kosmidis, Irene Grimani, Nicholas Pavlidis, D. Bafaloukos, Dimitrios Pectasides, Meletios A Dimopoulos
George Bozas, Efstathios Kastritis, Alexandros Rodolakis, George Vlahos, Christos Papadimitriou, S. Markaki, Dimitra Gika, Aristotelis Bamias, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.